it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.at UBS. The firm is bullish on the stock thanks to progress on legacy projects and said Fluor is on the brink of a company turning point.Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly— Shares of Sunrun and Sunnova dropped 3% and 2.
— The pharma stock rose slightly after Moderna announced positive interim results from the Phase 1/2 trial of mRNA-1083, an investigational combination vaccine against influenza and Covid. Moderna said in a press release it plans to begin a Phase 3 trial of the combination vaccine in 2023, working to accomplish potential regulatory approval in 2025.— The Israel-based beauty stock, which owns direct-to-consumer brands Il Makiage and SpoiledChild, added 3.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »
Fonte: Investingcom - 🏆 450. / 53 Consulte Mais informação »
Fonte: MarketWatch - 🏆 3. / 97 Consulte Mais informação »